Pregled bibliografske jedinice broj: 1264304
Where are we going from here?
Where are we going from here? // Arhiv za higijenu rada i toksikologiju
Zagreb, Hrvatska, 2023. str. A19-A19 (pozvano predavanje, podatak o recenziji nije dostupan, sažetak, znanstveni)
CROSBI ID: 1264304 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Where are we going from here?
Autori
Katalinić, Maja
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Arhiv za higijenu rada i toksikologiju
/ - , 2023, A19-A19
Skup
Cell-Based Research in Toxicology and Drug Design
Mjesto i datum
Zagreb, Hrvatska, 26.01.2023
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Podatak o recenziji nije dostupan
Ključne riječi
cytotoxicity ; cancer ; repurposing ; PAINS ; oximes ; MAO ; nicotinic
Sažetak
Based on the results obtained within the CellToxTargets project, we have set the direction for continuation of the study addressing biological activity perspectives for designed reversible cholinesterase ligands. Namely, we will screen the wider activity of several defined sets of designed cholinesterases’ ligands, that have shown previously in our study to affect cells beyond influencing cholinesterases. With this, we hypothesize identifying compounds with a potential to be developed into drugs for other important therapeutic areas such as diseases affecting multiple cell types (cancer, diabetes, neurodegenerative disorders, muscle diseases etc.). Firstly, we will focus our research on determining to what extent selected compounds alter activity of validated drug targets of choice (like monoamine oxidase, cytochrome enzymes, nicotinic acetylcholine receptor or glucose transporters). Secondly, we will look into the anticancer potential of selected compounds, in example, on prostate and breast cancer cells. Additionally, we will determine the metabolic stability and biotransformation of tested compounds to get the full profile of their potential to be developed into drugs. Within the scope of our future research, we will elucidate whether any of the tested compounds falls into the category of the so-called Pan-Assay Interference Compounds (PAINS), or chemical compounds that often give false positive results in high-throughput screens. Namely, PAINS more likely react nonspecifically with numerous biological targets rather than specifically affecting one desired target, misleading the research and conclusions on the overall biological activity. This research was supported by the Croatian Science Foundation UIP-2017-05-7260.
Izvorni jezik
Engleski
Znanstvena područja
Kemija, Biologija
POVEZANOST RADA
Projekti:
UIP-2017-05-7260 - MOLEKULARNI MEHANIZMI TOKSIČNOSTI PROTUOTROVA I POTENCIJALNIH LIJEKOVA (CellToxTargets) (Katalinić, Maja, HRZZ - 2017-05) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Maja Katalinić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE